200,000+ products from a single source!

sales@angenechem.com

Home > Amines > 170230-39-4

170230-39-4

170230-39-4 | N-(3-(2-(Dimethylamino)ethoxy)-4-methoxyphenyl)-2'-methyl-4'-(5-methyl-1,2,4-oxadiazol-3-yl)-[1,1'-biphenyl]-4-carboxamide

CAS No: 170230-39-4 Catalog No: AG003U7E MDL No:

Product Description

Catalog Number:
AG003U7E
Chemical Name:
N-(3-(2-(Dimethylamino)ethoxy)-4-methoxyphenyl)-2'-methyl-4'-(5-methyl-1,2,4-oxadiazol-3-yl)-[1,1'-biphenyl]-4-carboxamide
CAS Number:
170230-39-4
Molecular Formula:
C28H30N4O4
Molecular Weight:
486.5622
IUPAC Name:
N-[3-[2-(dimethylamino)ethoxy]-4-methoxyphenyl]-4-[2-methyl-4-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]benzamide
InChI:
InChI=1S/C28H30N4O4/c1-18-16-22(27-29-19(2)36-31-27)10-12-24(18)20-6-8-21(9-7-20)28(33)30-23-11-13-25(34-5)26(17-23)35-15-14-32(3)4/h6-13,16-17H,14-15H2,1-5H3,(H,30,33)
InChI Key:
JRNUKVFYILMMLX-UHFFFAOYSA-N
SMILES:
COc1ccc(cc1OCCN(C)C)NC(=O)c1ccc(cc1)c1ccc(cc1C)c1noc(n1)C
UNII:
ZM4360761C

Properties

Complexity:
687  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
486.227g/mol
Formal Charge:
0
Heavy Atom Count:
36  
Hydrogen Bond Acceptor Count:
7  
Hydrogen Bond Donor Count:
1  
Isotope Atom Count:
0
Molecular Weight:
486.572g/mol
Monoisotopic Mass:
486.227g/mol
Rotatable Bond Count:
9  
Topological Polar Surface Area:
89.7A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
5  

Literature

Title Journal
The effect of serotonin 5HT1B receptor ligands on amphetamine self-administration in rats. European journal of pharmacology 20120227
Neonatal DSP-4 treatment impairs 5-HT(1B) receptor reactivity in adult rats. Behavioral and biochemical studies. Pharmacological reports : PR 20100101
Regulation of serotonin 1B receptor by glycogen synthase kinase-3. Molecular pharmacology 20091201
5-HT inhibits synaptic transmission in rat subthalamic nucleus neurons in vitro. Neuroscience 20080219
Effects of serotonin (5-HT)(1B) receptor ligands on cocaine-seeking behavior in rats. Pharmacological reports : PR 20080101
Effects of serotonin 5-HT1B receptor ligands on the cocaine- and food-maintained self-administration in rats. European journal of pharmacology 20070322
Differential role of 5-HT1A and 5-HT1B receptors on the antinociceptive and antidepressant effect of tramadol in mice. Psychopharmacology 20060901
Anticonvulsant effect of the selective 5-HT1B receptor agonist CP 94253 in mice. European journal of pharmacology 20060710
Involvement of 5-HT1B receptors within the ventral tegmental area in ethanol-induced increases in mesolimbic dopaminergic transmission. Brain research 20051026
Antidepressant-like effect of the selective 5-HT1B receptor agonist CP 94253: a possible mechanism of action. European journal of pharmacology 20050523
Role of 5-HT1A and 5-HT1B receptors in the antinociceptive effect of tramadol. European journal of pharmacology 20050321
Role of 5-HT1A and 5-HT1B receptors in the hypophagic effect of 5-HT on the structure of feeding behavior. Medical science monitor : international medical journal of experimental and clinical research 20050301
The anxiolytic-like effect of 5-HT1B receptor ligands in rats: a possible mechanism of action. The Journal of pharmacy and pharmacology 20050201
Effects of a selective 5-HT1B receptor agonist and antagonists in animal models of anxiety and depression. Behavioural pharmacology 20041201
Involvement of 5-HT1B receptors within the ventral tegmental area in regulation of mesolimbic dopaminergic neuronal activity via GABA mechanisms: a study with dual-probe microdialysis. Brain research 20040917
Involvement of 5-HT1B receptors in triptan-induced contractile responses in guinea-pig isolated iliac artery. Naunyn-Schmiedeberg's archives of pharmacology 20040701
Effect of combined administration of 5-HT1A or 5-HT1B/1D receptor antagonists and antidepressants in the forced swimming test. European journal of pharmacology 20040308
5-Hydroxytryptamine 1B receptors mediate presynaptic inhibition of monosynaptic IPSC in the rat dorsolateral septal nucleus. Neuroscience research 20040301
Role of 5-HT1B/D receptors in canine gastric accommodation: effect of sumatriptan and 5-HT1B/D receptor antagonists. American journal of physiology. Gastrointestinal and liver physiology 20030701
The role of 5-HT1A/B autoreceptors in the antinociceptive effect of systemic administration of acetaminophen. Anesthesiology 20030301
Triptans reduce the inflammatory response in bacterial meningitis. Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 20020801
Parabrachial infusion of D-fenfluramine reduces food intake. Blockade by the 5-HT(1B) antagonist SB-216641. Pharmacology, biochemistry, and behavior 20020401
Serotonin-1B receptor-mediated inhibition of [(3)H]GABA release from rat ventral tegmental area slices. Journal of neurochemistry 20011101
Role of 5-HT(1B) receptors in the sensitization to amphetamine in mice. European journal of pharmacology 20010622
Multiple 5-HT(1) autoreceptor subtypes govern serotonin release in dorsal and median raphé nuclei. Neuropharmacology 20010301
The selective 5-HT1B receptor inverse agonist 1'-methyl-5-[[2'-methyl-4'-(5-methyl-1,2, 4-oxadiazol-3-yl)biphenyl-4-yl]carbonyl]-2,3,6,7-tetrahydro- spiro[furo[2,3-f]indole-3,4'-piperidine] (SB-224289) potently blocks terminal 5-HT autoreceptor function both in vitro and in vivo. Journal of medicinal chemistry 19980409
SB-216641 and BRL-15572--compounds to pharmacologically discriminate h5-HT1B and h5-HT1D receptors. Naunyn-Schmiedeberg's archives of pharmacology 19970901

Related Products

© 2019 Angene International Limited. All rights Reserved.